COGT
Price
$9.90
Change
-$0.50 (-4.81%)
Updated
Nov 14, 03:18 PM (EDT)
124 days until earnings call
SPHDF
Price
$11.70
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

COGT vs SPHDF

Header iconCOGT vs SPHDF Comparison
Open Charts COGT vs SPHDFBanner chart's image
Cogent Biosciences
Price$9.90
Change-$0.50 (-4.81%)
Volume$5.38K
CapitalizationN/A
Santhera Pharmaceuticals Holdings
Price$11.70
Change-$0.00 (-0.00%)
Volume$300
CapitalizationN/A
COGT vs SPHDF Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
COGT vs. SPHDF commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Sell and SPHDF is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (COGT: $10.40 vs. SPHDF: $11.70)
Brand notoriety: COGT and SPHDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 243% vs. SPHDF: 100%
Market capitalization -- COGT: $1.14B vs. SPHDF: $115.5M
COGT [@Biotechnology] is valued at $1.14B. SPHDF’s [@Biotechnology] market capitalization is $115.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileSPHDF’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • SPHDF’s FA Score: 0 green, 5 red.
According to our system of comparison, COGT is a better buy in the long-term than SPHDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish.

  • COGT’s TA Score: 5 bullish, 5 bearish.

Price Growth

COGT (@Biotechnology) experienced а -0.76% price change this week, while SPHDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.82%. For the same industry, the average monthly price growth was +4.53%, and the average quarterly price growth was +7.12%.

Reported Earning Dates

COGT is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (-0.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.14B) has a higher market cap than SPHDF($116M). COGT YTD gains are higher at: 76.871 vs. SPHDF (0.000).
COGTSPHDFCOGT / SPHDF
Capitalization1.14B116M981%
EBITDA-240.8MN/A-
Gain YTD76.8710.000-
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash363MN/A-
Total Debt18.2MN/A-
FUNDAMENTALS RATINGS
COGT vs SPHDF: Fundamental Ratings
COGT
SPHDF
OUTLOOK RATING
1..100
1040
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
62100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4370
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SPHDF's Valuation (68) in the null industry is in the same range as COGT (80) in the Miscellaneous industry. This means that SPHDF’s stock grew similarly to COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (62) in the Miscellaneous industry is somewhat better than the same rating for SPHDF (100) in the null industry. This means that COGT’s stock grew somewhat faster than SPHDF’s over the last 12 months.

COGT's SMR Rating (97) in the Miscellaneous industry is in the same range as SPHDF (100) in the null industry. This means that COGT’s stock grew similarly to SPHDF’s over the last 12 months.

COGT's Price Growth Rating (43) in the Miscellaneous industry is in the same range as SPHDF (70) in the null industry. This means that COGT’s stock grew similarly to SPHDF’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as SPHDF (100) in the null industry. This means that COGT’s stock grew similarly to SPHDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BGNE195.551.91
+0.99%
BeiGene Ltd
SLDB5.560.05
+0.91%
Solid Biosciences
MAN63.790.38
+0.60%
ManpowerGroup
SII42.33-0.47
-1.10%
Sprott
GIPR1.83-0.07
-3.68%
Generation Income Properties

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+0.19%
SPHDF - COGT
63%
Loosely correlated
N/A
SNDX - COGT
51%
Loosely correlated
+2.65%
KROS - COGT
43%
Loosely correlated
-2.79%
MEOBF - COGT
39%
Loosely correlated
-0.72%
TNFA - COGT
39%
Loosely correlated
-3.47%
More

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with TRML. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then TRML could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
N/A
TRML - SPHDF
78%
Closely correlated
+0.61%
COGT - SPHDF
63%
Loosely correlated
+0.19%
MEOBF - SPHDF
50%
Loosely correlated
-0.72%
KROS - SPHDF
38%
Loosely correlated
-2.79%
CYTO - SPHDF
35%
Loosely correlated
-9.87%
More